Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis

References

• SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
   PubMed Web of Science ®Google Scholar
• SiegelRDeSantisCVirgoKCancer treatment and survivorship statistics, 2012CA Cancer J Clin20126222024122700443
   PubMed Web of Science ®Google Scholar
• MolinaJRYangPCassiviSDSchildSEAdjeiAANon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipMayo Clin Proc200883558459418452692
   PubMed Web of Science ®Google Scholar
• PaesmansMSculierJPLibertPPrognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working PartyJ Clin Oncol1995135122112307738625
   PubMed Web of Science ®Google Scholar
• DonnemTBremnesRMBusundLTAndersenSPezzellaFGene expression assays as prognostic and predictive markers in early stage non-small cell lung cancerJ Thorac Dis20124221221322833829
   PubMed Web of Science ®Google Scholar
• OsarogiagbonRUPredicting survival of patients with resectable non-small cell lung cancer: Beyond TNMJ Thorac Dis20124221421622833830
   PubMed Web of Science ®Google Scholar
• KarachaliouNRosellRSystemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyondCancer Biol Med201411317318125364578
   PubMed Web of Science ®Google Scholar
• KnickelbeinKZhangLMutant KRAS as a critical determinant of the therapeutic response of colorectal cancerGenes Dis2014241225815366
   PubMedGoogle Scholar
• SadeghiSOlevskyOHurvitzSAProfiling and targeting HER2-positive breast cancer using trastuzumab emtansinePharmgenomics Pers Med2014732933825378946
   PubMedGoogle Scholar
• DrakeCGJaffeeEPardollDMMechanisms of immune evasion by tumorsAdv Immunol200690518116730261
   PubMed Web of Science ®Google Scholar
• AgataYKawasakiANishimuraHExpression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInt Immunol1996857657728671665
   PubMed Web of Science ®Google Scholar
• SznolMChenLAntagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancerClin Cancer Res20131951021103423460533
   PubMed Web of Science ®Google Scholar
• BlankCBrownIPetersonACPD-L1/B7–H1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cellsCancer Res20046431140114514871849
   PubMed Web of Science ®Google Scholar
• HaspotFFehrTGibbonsCPeripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathwayBlood200811252149215518577709
   PubMed Web of Science ®Google Scholar
• ZouWChenLInhibitory B7-family molecules in the tumor microen-vironmentNat Rev Immunol20088646747718500231
   PubMed Web of Science ®Google Scholar
• MischingerJFroehlichEGriesbacherAPrognostic relevance of B7H1 and B7H3 protein expressions in metastatic clear cell renal cell carcinomaJ Clin Oncol201028Supplabstract e150674
   Google Scholar
• TaubeJMAndersRAYoungGDColocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escapeSci Transl Med20124127127137
   Web of Science ®Google Scholar
• MuCYHuangJAChenYChenCZhangXGHigh expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturationMed Oncol201128368268820373055
   PubMed Web of Science ®Google Scholar
• MaWLuoDZChenYDangYWExpression and clinical significance of PD-L1 and PD-1 in non-small cell lung cancerJ Pract Med20112715511554
   Google Scholar
• ChenYBMuCYHuangJAClinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up studyTumori201298675175523389362
   PubMed Web of Science ®Google Scholar
• ZhangYWangLLiYProtein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinomaOnco Targets Ther2014756757324748806
   PubMed Web of Science ®Google Scholar
• YangCYLinMWChangYLWuCTYangPCProgrammed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomesEur J Cancer20145071361136924548766
   PubMed Web of Science ®Google Scholar
• VelchetiVSchalperKACarvajalDEProgrammed death ligand-1 expression in non-small cell lung cancerLab Invest201494110711624217091
   PubMed Web of Science ®Google Scholar
• D’InceccoAAndreozziMLudoviniVPD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsBr J Cancer201511219510225349974
   PubMed Web of Science ®Google Scholar
• AzumaKOtaKKawaharaAAssociation of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancerAnn Oncol201425101935194025009014
   PubMed Web of Science ®Google Scholar
• MaoYLiWChenKB7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancerOncotarget2015653452346125609202
   PubMedGoogle Scholar
• LinCChenXLiMProgrammed death-ligand 1 expression predicts tyrosine kinase inhibitor response and better prognosis in a cohort of patients with epidermal growth factor receptor mutation-positive lung adenocarcinomaClin Lung Cancer2015165e25e3525801750
   PubMed Web of Science ®Google Scholar
• TangYFangWZhangYThe association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIsOncotarget2015616142091421925895031
   PubMedGoogle Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementJ Clin Epidemiol200962101006101219631508
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• YlmazMBayazitYACiftciTUAssociation of serotonin transporter gene polymorphism with obstructive sleep apnea syndromeLaryngoscope2005115583283615867649
   PubMed Web of Science ®Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMDaveySGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• ZhouZJZhanPSongYPD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysisTransl Lung Cancer Res20154220320825870804
   PubMed Web of Science ®Google Scholar
• WangAWangHYLiuYThe prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysisEur J Surg Oncol201541445045625682184
   PubMed Web of Science ®Google Scholar
• ZhangYKangSShenJPrognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) expression in epithelial-originated cancer: a meta-analysisMedicine (Baltimore)2015946e51525674748
   PubMed Web of Science ®Google Scholar
• PanZKYeFWuXAnHXWuJXClinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysisJ Thorac Dis20157346247025922726
   PubMed Web of Science ®Google Scholar